Home
About +
Our Story
Meet the Team
FAQs
Our Science +
Inhaled IFN-β
Clinical Trials
Publications
Investors +
Share Price Information
Reports & Presentations
Investor News
Shareholder Information
AIM Rule 26
Corporate Governance
Investor Calendar
News +
Press Releases
Resources
Factsheets
TR-1/Options Press Releases
Careers
Contact
Home
About
Our Science
Investors
News
Careers
Contact
Back
Our Story
Meet the Team
FAQs
Back
Inhaled IFN-β
Clinical Trials
Publications
Back
Share Price Information
Reports & Presentations
Investor News
Shareholder Information
AIM Rule 26
Corporate Governance
Investor Calendar
Back
Press Releases
Resources
Factsheets
TR-1/Options Press Releases
News
TR-1/Options Press Releases
2022
2021
2020
2019
2018
Holding(s) in Company
6th October 2022
Grant of Options
6th July 2022
Holding(s) in Company
15th June 2022
Exercise of Options and Total Voting Rights
9th June 2022
Holding(s) in Company
6th April 2022
Holding(s) in Company
8th March 2022
Holding(s) in Company
8th March 2022
Holding(s) in Company
4th March 2022
Holding(s) in Company
24th February 2022
Holding(s) in Company
23rd February 2022
Holding(s) in Company
4th February 2022
Director/PDMR Shareholding
28th January 2022
Holding(s) in Company
19th January 2022
Holding(s) in Company
12th January 2022
Holding(s) in Company
7th January 2022